RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+22.82%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$1.54B
AUM Growth
+$1.54B
(+33%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
12.08%
Top 10 Holdings %
Top 10 Hldgs %
42.85%
Holding
66
New
16
Increased
21
Reduced
18
Closed
6
Top Buys
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$29.1M |
| 2 |
Neurocrine Biosciences
NBIX
|
$26.9M |
| 3 |
ICU Medical
ICUI
|
$24.5M |
| 4 |
Regenxbio
RGNX
|
$24.5M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$22.8M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$51.8M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$47.7M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$41.2M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$34.4M |
| 5 |
Centene
CNC
|
$29.2M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 0.93% |
| 3 | Communication Services | 0.56% |
| 4 | Technology | 0% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $114M | 7.41% | 12,765,862 -3,852,914 | -23% | -$34.4M |
|
2
Penumbra
PEN
$10.6B
| $86.3M | 5.6% | 1,034,408 -5,800 | -0.6% | -$484K |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $81.1M | 5.26% | 11,375,852 -955,278 | -8% | -$6.81M |
|
4
Puma Biotechnology
PBYI
$254M
| $64.2M | 4.17% | 1,725,414 +435,274 | +34% | +$16.2M |
|
|
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
| $61.9M | 4.02% | 972,696 -647,659 | -40% | -$41.2M |
|
6
Atara Biotherapeutics
ATRA
$84.6M
| $56.2M | 3.65% | 2,734,118 +63,176 | +2% | +$1.3M |
|
7
Agios Pharmaceuticals
AGIO
$2.19B
| $52.7M | 3.42% | 902,578 +164,127 | +22% | +$9.59M |
|
8
Molina Healthcare
MOH
$9.8B
| $52.4M | 3.4% | 1,149,727 +344,181 | +43% | +$15.7M |
|
9
Prothena Corp
PRTA
$441M
| $47.4M | 3.08% | 849,483 +195,758 | +30% | +$10.9M |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $43.8M | 2.84% | 696,386 -824,518 | -54% | -$51.8M |
|
11
Incyte
INCY
$16.5B
| $41.1M | 2.67% | 307,723 -144,264 | -32% | -$19.3M |
|
|
GWPH
12
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $40.2M | 2.61% | 332,544 -33,524 | -9% | -$4.05M |
|
|
ALDR
13
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $39.7M | 2.58% | 1,909,886 +989,336 | +107% | +$20.6M |
|
14
Xencor
XNCR
$580M
| $38.1M | 2.47% | 1,592,526 +596,426 | +60% | +$14.3M |
|
15
Wave Life Sciences
WVE
$1.53B
| $35M | 2.27% | 1,271,097 +319,385 | +34% | +$8.78M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $34.4M | 2.23% | 934,343 +617,943 | +195% | +$22.8M |
|
|
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $31.1M | 2.02% | 2,004,849 +303,800 | +18% | +$4.71M |
|
18
Boston Scientific
BSX
$156B
| $29.8M | 1.94% | 1,200,099 +740,594 | +161% | +$18.4M |
|
|
SYNH
19
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $29.1M | 1.89% | +633,779 | New | +$29.1M |
|
20
Elevance Health
ELV
$71.8B
| $29M | 1.88% | 175,328 +98,105 | +127% | +$16.2M |
|
|
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
| $27.6M | 1.79% | 4,325,055 +979,096 | +29% | +$6.25M |
|
|
22
Neurocrine Biosciences
NBIX
$13.8B
| $26.9M | 1.75% | +622,345 | New | +$26.9M |
|
|
NDRM
23
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $24.5M | 1.59% | 924,304 -636,515 | -41% | -$16.9M |
|
|
24
ICU Medical
ICUI
$3.15B
| $24.5M | 1.59% | +160,543 | New | +$24.5M |
|
|
25
Regenxbio
RGNX
$451M
| $24.5M | 1.59% | +1,269,131 | New | +$24.5M |
|